Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
11 studies found for:    cholangiocarcinoma AND klatskin's tumor | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma
Condition: Hilar Cholangiocarcinoma
Interventions: Procedure: PDT-Deuteporfin(6 hour);   Procedure: PDT-Deuteporfin(9 hour);   Device: stenting
2 Recruiting Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma
Condition: Hilar Cholangiocarcinoma
Interventions: Procedure: bilateral metal stent insertion;   Procedure: unilateral metal stent insertion
3 Recruiting Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Morphological Diagnosis of Hilar Cholangiocarcinoma (Excluded Type 1), Resectable With Expected R0 Margins on an intent-to Treat Basis.
Interventions: Procedure: CAPECITABINE-Radiotherapy -Liver Transplantation;   Procedure: RESECTION
4 Recruiting A Phase II Trial of LDK378 in ROS1 and /or ALK Over-expressed Advanced Intrahepatic or Hilar Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Drug: LDK378
5 Not yet recruiting Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma
Condition: Cholangitis
Intervention: Procedure: Injection of 37℃ contrast agent
6 Recruiting Photodynamic Therapy in Locally Advanced Hilar Cholangiocarcinoma
Conditions: Treatment Response;   Adverse Events;   Feasibility
Intervention: Procedure: Photodynamic therapy
7 Recruiting Best Biliary Drainage Option in Advanced Klatskin Tumor
Condition: Cholangitis
Interventions: Procedure: ERCP Drainage;   Procedure: PTBD Drainage
8 Recruiting Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers
Conditions: Cholangiocarcinoma;   Tumor;   Klatskin Tumor
Intervention: Drug: Temoporfin
9 Not yet recruiting Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma
Conditions: Non-Resectable Cholangiocarcinoma;   Recurrent Cholangiocarcinoma;   Stage III Extrahepatic Bile Duct Cancer;   Stage III Intrahepatic Cholangiocarcinoma;   Stage IIIA Hilar Cholangiocarcinoma;   Stage IIIB Hilar Cholangiocarcinoma;   Stage IVA Extrahepatic Bile Duct Cancer;   Stage IVA Hilar Cholangiocarcinoma;   Stage IVA Intrahepatic Cholangiocarcinoma;   Stage IVB Extrahepatic Bile Duct Cancer;   Stage IVB Hilar Cholangiocarcinoma;   Stage IVB Intrahepatic Cholangiocarcinoma;   Unresectable Extrahepatic Bile Duct Carcinoma
Interventions: Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Ricolinostat
10 Not yet recruiting Superior Bilioenteric Anastomosis by Magnetic Compressive Technique
Conditions: Hilar Cholangiocarcinoma;   Bile Duct Injury;   Choledochal Cyst;   Biliary Calculi
Interventions: Device: Magnetic Compressive Anastomosis;   Procedure: Manual Anastomosis
11 Not yet recruiting Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient
Conditions: Biliary Obstructive Disease Such as Choledocholithiasis;   Benign Biliary Stricture;   Peri-ampullary Cancer;   Bile Duct Cancer Resectable;   Klatskin Tumor
Interventions: Biological: Pacetin® (cefoxitin);   Biological: Placebo

Study has passed its completion date and status has not been verified in more than two years.